130 related articles for article (PubMed ID: 12644316)
1. Skewed inhibitory receptors expression in a TAP2-deficient patient.
Crespí C; Rosa Julià M; Muñoz-Saa I; Pérez-Castellano MT; Milà J; Matamoros N
Immunol Lett; 2003 Apr; 86(2):149-53. PubMed ID: 12644316
[TBL] [Abstract][Full Text] [Related]
2. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy.
Barakonyi A; Kovacs KT; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2002 Mar; 168(6):2683-8. PubMed ID: 11884433
[TBL] [Abstract][Full Text] [Related]
3. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
4. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency.
Matamoros N; Milà J; Llano M; Balas A; Vicario JL; Pons J; Crespí C; Martinez N; Iglesias-Alzueta J; López-Botet M
Clin Exp Immunol; 2001 Aug; 125(2):274-82. PubMed ID: 11529920
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of natural killer receptors on Vdelta1 gammadelta T cells in HIV-1-infected individuals.
Wesch D; Kabelitz D
J Acquir Immune Defic Syndr; 2003 Aug; 33(4):420-5. PubMed ID: 12869830
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
Harly C; Peyrat MA; Netzer S; Déchanet-Merville J; Bonneville M; Scotet E
Blood; 2011 Mar; 117(10):2864-73. PubMed ID: 21233315
[TBL] [Abstract][Full Text] [Related]
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
8. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
[TBL] [Abstract][Full Text] [Related]
9. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
10. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vgamma9 Vdelta2 T cells but not on CD94- thymic or mature gammadelta T cell clones.
Boullier S; Poquet Y; Halary F; Bonneville M; Fournie JJ; Gougeon ML
Eur J Immunol; 1998 Nov; 28(11):3399-410. PubMed ID: 9842883
[TBL] [Abstract][Full Text] [Related]
11. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
12. Gamma/deltaT-cell subsets, NKG2A expression and apoptosis of Vdelta2+ T cells in pregnant women with or without risk of premature pregnancy termination.
Szereday L; Barakonyi A; Miko E; Varga P; Szekeres-Bartho J
Am J Reprod Immunol; 2003 Dec; 50(6):490-6. PubMed ID: 14750557
[TBL] [Abstract][Full Text] [Related]
13. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F; Kabat J; Sanni TB; Coligan JE
J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
[TBL] [Abstract][Full Text] [Related]
14. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells.
Lafarge X; Pitard V; Ravet S; Roumanes D; Halary F; Dromer C; Vivier E; Paul P; Moreau JF; Déchanet-Merville J
Eur J Immunol; 2005 Jun; 35(6):1896-905. PubMed ID: 15864777
[TBL] [Abstract][Full Text] [Related]
15. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
16. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
[TBL] [Abstract][Full Text] [Related]
17. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
[TBL] [Abstract][Full Text] [Related]
18. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
19. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells.
Vitale M; Zimmer J; Castriconi R; Hanau D; Donato L; Bottino C; Moretta L; de la Salle H; Moretta A
Blood; 2002 Mar; 99(5):1723-9. PubMed ID: 11861289
[TBL] [Abstract][Full Text] [Related]
20. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
